ArticlePharmaceuticals (Basel, Switzerland)2022

Afatinib Reverses EMT via Inhibiting CD44-Stat3 Axis to Promote Radiosensitivity in Nasopharyngeal Carcinoma.

Huichao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.